Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 1, 2010, Pages 26-31

  Sáiz, Pilar A ^a   García Portilla, M Paz ^a   Arango, Celso ^b   Morales, Blanca ^c   Arias, Bárbara ^d   Corcoran, Paul ^a,e   Fernández, Juan M ^a   Alvarez, Victoria ^c   Coto, Eliecer ^c   Bascarán, María Teresa ^a   Bousoño, Manuel ^a   Fañanas, Lourdes ^d   Bobes, Julio ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e NATIONAL SUICIDE RESEARCH FOUNDATION   (Ireland)

Author keywords

Dopamine D2 receptor; Dopamine D3 receptor; Dopamine transporter; Genetic association; Schizophrenia

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE TRANSPORTER; PROTEIN SLC6A3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA;

ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SCHIZOPHRENIA; SPAIN; YOUNG ADULT;

EID: 73849123012     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.09.008     Document Type: Article

References (76)

1. Arinami T., Gao M., Hamaguchi H., and Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 6 (1997) 577-582
2. Bannon M.J., Michelhaugh S.K., Wang J., and Sacchetti P. The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. Eur Neuropsychopharmacol 11 (2001) 449-455
3. Baritaki S., Rizos E., Zafiropoulos A., Soufla G., Katsafouros K., Gourvas V., et al. Association between schizophrenia and DRD3 or HTR2 receptor gene variants. Eur J Hum Genet 12 (2004) 535-541
4. Bodeau-Pean S., Laurent C., Campion D., Jay M., Thibaut F., Dollfus S., et al. No evidence for linkage or association between the dopamine transporter gene and schizophrenia in a French population. Psychiatry Res 59 (1995) 1-6
5. Breen G., Brown J., Maude S., Fox H., Collier D., Li T., et al. 141 C del/ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population. Am J Med Genet 88 (1999) 407-410
6. Bulayeva K.B., Glatt S.J., Bulayev O.A., Pavlova T.A., and Tsuang M.T. Genome-wide linkage scan of schizophrenia: a cross-isolate study. Genomics 89 (2007) 167-177
7. Calafell F., and Bertranpetit J. Principal component analysis of gene frequencies and the origin of Basques. Am J Phys Anthropol 93 (1994) 201-215
8. Cardno A.G., and Gottesman I.I. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 97 (2000) 12-17
9. Carlsson A., and Lindqvist M. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 20 (1963) 140-144
10. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropharmacology 1 (1988) 179-185
11. Chen C.H., Liu M.Y., Wei F.C., Koong F.J., Hwu H.G., and Hsiao K.J. Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene and schizophrenia. Am J Med Genet 74 (1997) 40-43
12. Cordeiro Q., Talkowski M., Wood J., Ikenaga E., and Vallada H. Lack of association between VNTR polymorphism of dopamine transporter gene (SLC6A3) and schizophrenia in a Brazilian sample. Arq Neuropsiquiatr 62 (2004) 973-976
13. Crocq M.A., Mant R., Asherson P., Williams J., Hode Y., Mayerova A., et al. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 29 (1992) 858-860
14. Daniels J., Williams J., Asherson P., McGuffin P., and Owen M. No association between schizophrenia and polymorphisms within the genes for debrisoquine 4-hydroxylase (CYP2D6) and the dopamine transporter (DAT). Am J Med Genet 60 (1995) 85-87
15. Dominguez E., Loza M.I., Padin F., Gesteira A., Paz E., Paramo M., et al. Extensive linkage disequilibrium mapping at HTR2A and DRD3 for schizophrenia susceptibility genes in the Galician population. Schizophr Res 90 (2007) 123-129
16. Dubertret C., Gorwood P., Ades J., Feingold J., Schwartz J.C., and Sokoloff P. Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians. Am J Med Genet 81 (1998) 318-322
17. Dubertret C., Gouya L., Hanoun N., Deybach J.C., Ades J., Hamon M., et al. The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia. Schizophr Res 67 (2004) 75-85
18. European network of schizophrenia networks for the study of gene-environment interactions. Schizophrenia aetiology: do gene-environment interactions hold the key?. Schizophr Res 102 (2008) 21-26
19. Fathalli F., Rouleau G.A., Xiong L., Tabbane K., Benkelfat C., Deguzman R., et al. No association between the DRD3 Ser9Gly polymorphism and schizophrenia. Schizophr Res 98 (2008) 98-104
20. Fuke S., Suo S., Takahashi N., Koike H., Sasagawa N., and Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 1 (2001) 152-156
21. Gaitonde E.J., Morris A., Sivagnanasundaram S., McKenna P.J., Hunt D.M., and Mollon J.D. Assessment of association of D3 dopamine receptor MscI polymorphism with schizophrenia: analysis of symptom ratings, family history, age at onset, and movement disorders. Am J Med Genet 67 (1996) 455-458
22. Gamma F., Faraone S.V., Glatt S.J., Yeh Y.C., and Tsuang M.T. Meta-analysis shows schizophrenia is not associated with the 40-base-pair repeat polymorphism of the dopamine transporter gene. Schizophr Res 73 (2005) 55-58
23. Giros B., el Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., et al. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 42 (1992) 383-390
24. Glatt S.J., Faraone S.V., and Tsuang M.T. DRD2-141C insertion/deletion polymorphism is not associated with schizophrenia: results of a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 128 (2004) 21-23
25. Grandy D.K., Litt M., Allen L., Bunzow J.R., Marchionni M., Makam H., et al. The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 45 (1989) 778-785
26. Heinz A., Goldman D., Jones D.W., Palmour R., Hommer D., Gorey J.G., et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22 (2000) 133-139
27. Himei A., Koh J., Sakai J., Inada Y., Akabame K., and Yoneda H. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and - 141C Ins/Del polymorphisms. Psychiatry Clin Neurosci 56 (2002) 97-102
28. Hori H., Ohmori O., Shinkai T., Kojima H., and Nakamura J. Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia. Am J Med Genet 105 (2001) 176-178
29. Inada T., Sugita T., Dobashi I., Inagaki A., Kitao Y., Matsuda G., et al. Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode. Am J Med Genet 67 (1996) 406-408
30. Inada T., Arinami T., and Yagi G. Association between a polymorphism in the promoter region of the dopamine D2 receptor gene and schizophrenia in Japanese subjects: replication and evaluation for antipsychotic-related features. Int J Neuropsychopharmcol 2 (1999) 181-186
31. Jaber M., Jones S., Giros B., and Caron M.G. The dopamine transporter: a crucial component regulating dopamine transmission. Mov Disord 12 (1997) 629-633
32. Jacobsen L.K., Staley J.K., Zoghbi S.S., Seibyl J.P., Kosten T.R., Innis R.B., et al. Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry 157 (2000) 1700-1703
33. Jeong S.H., Joo E.J., Ahn Y.M., and Kim Y.S. Association study of dopamine transporter gene and schizophrenia in Korean population using multiple single nucleotide polymorphism markers. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 975-983
34. Jönsson E., Lannfelt L., Sokoloff P., Schwartz J.C., and Sedvall G. Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene. Acta Psychiatr Scand 87 (1993) 345-349
35. Jönsson E.G., Nothen M.M., Neidt H., Forslund K., Rylander G., Mattila-Evenden M., et al. Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia. Schizophr Res 40 (1999) 31-36
36. Jönsson E.G., Nothen M.M., Grunhage F., Farde L., Nakashima Y., Propping P., et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4 (1999) 290-296
37. Jönsson E.G., Sillén A., Vares M., Ekholm B., Terenius L., and Sedvall G.C. Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis. Am J Med Genet B Neuropsychiatr Genet 119B (2003) 28-34
38. Jönsson E.G., Flyckt L., Burgert E., Crocq M.A., Forslund K., Mattila-Evenden M., et al. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatr Genet 13 (2003) 1-12
39. Jönsson E.G., Kaiser R., Brockmöller J., Nimgaonkar V.L., and Crocq M.A. Meta-analysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia. Psychiatr Genet 14 (2004) 9-12
40. Joober R., Toulouse A., Benkelfat C., Lal S., Bloom D., Labelle A., et al. DRD3 and DAT1 genes in schizophrenia: an association study. J Psychiatr Res 34 (2000) 285-291
41. Kampman O., Anttila S., Illi A., Lehtimaki T., Mattila K.M., Roivas M., et al. Dopamine receptor D2-141C Insertion/Deletion polymorphism in a Finnish population with schizophrenia. Psychiatry Res 121 (2003) 89-92
42. Knable M.B., Hyde T.M., Herman M.M., Carter J.M., Bigelow L., and Kleinman J.E. Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients. Biol Psychiatry 36 (1994) 827-835
43. Lafuente A., Bernardo M., Mas S., Crescenti A., Aparici M., Gassó P., et al. Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics. Schizophr Res 90 (2007) 115-122
44. Lafuente A., Bernardo M., Mas S., Crescenti A., Aparici M., Gassó P., et al. 141C Ins/Del polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in a Spanish population. Psychiatr Genet 18 (2008) 122-127
45. Li T., Yang L., Wiese C., Xu C.T., Zeng Z., Giros B., et al. No association between alleles or genotypes at the dopamine transporter gene and schizophrenia. Psychiatry Res 52 (1994) 17-23
46. Li T., Arranz M., Aitchison K.J., Bryant C., Liu X., Kerwin R.W., et al. Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia. Schizophr Res 32 (1998) 87-92
47. Lundstrom K., and Turpin M.P. Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system. Biochem Biophys Res Commun 225 (1996) 1068-1072
48. Ma G., He Z., Fang W., Tang W., Huang K., Li Z., et al. The Ser9Gly polymorphism of the dopamine D3 receptor gene and risk of schizophrenia: an association study and a large meta-analysis. Schizophr Res 101 (2008) 26-35
49. Mant R., Williams J., Asherson P., Parfitt E., McGuffin P., and Owen M.J. Relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia. Am J Med Genet 54 (1994) 21-26
50. Martinez D., Gelernter J., Abi-Dargham A., van Dyck C.H., Kegeles L., Innis R.B., et al. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 24 (2001) 553-560
51. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
52. Nanko S., Sasaki T., Fukuda R., Hattori M., Dai X.Y., Kazamatsuri H., et al. A study of the association between schizophrenia and the dopamine D3 receptor gene. Hum Genet 92 (1993) 336-338
53. Ohara K., Nagai M., Tani K., Nakamura Y., Ino A., and Ohara K. Functional polymorphism of - 141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia. Psychiatry Res 81 (1998) 117-123
54. Parsons M.J., Mata I., Beperet M., Iribarren-Iriso F., Arroyo B., Sainz R., et al. A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate. Psychiatr Genet 17 (2007) 159-163
55. Persico A.M., and Macciardi F. Genotypic association between dopamine transporter gene polymorphisms and schizophrenia. Am J Med Genet 74 (1997) 53-57
56. Semwal P., Prasad S., Varma P.G., Bhagwat A.M., Deshpande S.N., and Thelma B.K. Candidate gene polymorphisms among North Indians and their association with schizophrenia in a case-control study. J Genet 81 (2002) 65-71
57. Shi J., Gershon E.S., and Liu C. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr Res 104 (2008) 96-107
58. Sokoloff P., Andrieux M., Besancon R., Pilon C., Martres M.P., Giros B., et al. Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. Eur J Pharmacol 225 (1992) 331-337
59. Spurlock G., Williams J., McGuffin P., Aschauer H.N., Lenzinger E., Fuchs K., et al. European multicentre association study of schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. Am J Med Genet 81 (1998) 24-28
60. Staddon S., Arranz M.J., Mancama D., Perez-Nievas F., Arrizabalaga I., Anney R., et al. Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population. Schizophr Res 73 (2005) 49-54
61. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, et al. Common variants conferring risk of schizophrenia. Nature 2009;460:744-7.
62. Stober G., Jatzke S., Heils A., Jungkunz G., Knapp M., Mossner R., et al. Insertion/deletion variant (- 141C Ins/Del) in the 5′ regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. J Neural Transm 105 (1998) 101-109
63. Talkowski M.E., Mansour H., Chowdari K.V., Wood J., Butler A., Varma P.G., et al. Novel, replicated associations between dopamine D3 receptor gene polymorphisms and schizophrenia in two independent samples. Biol Psychiatry 60 (2006) 570-577
64. Talkowski M.E., Bamne M., Mansour H., and Nimgaonkar V.L. Dopamine genes and schizophrenia: case closed or evidence pending?. Schizophr Bull 33 (2007) 1071-1081
65. Talkowski M.E., Kirov G., Bamne M., Georgieva L., Torres G., Mansour H., et al. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum Mol Genet 17 (2008) 747-758
66. Tallerico T., Ulpian C., and Liu I.S. Dopamine D2 receptor promoter polymorphism: no association with schizophrenia. Psychiatry Res 85 (1999) 215-219
67. Thomas D.C., and Witte J.S. Point: population stratification: a problem for case-control studies of candidate-gene associations?. Cancer Epidemiol Biomarkers Prev 11 (2002) 505-512
68. Utsunomiya K., Shinkai T., De Luca V., Hwang R., Sakata S., Fukunaka Y., et al. Genetic association between the dopamine D3 gene polymorphism (Ser9Gly) and schizophrenia in Japanese populations: evidence from a case-control study and meta-analysis. Neurosci Lett 444 (2008) 161-165
69. van Dyck C.H., Malison R.T., Jacobsen L.K., Seibyl J.P., Staley J.K., Laruelle M., et al. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 46 (2005) 745-751
70. van Munster BC, Yazdanpanah M, Tanck MW, de Rooij SE, van de Giessen E, Sijbrands EJ, et al. Genetic polymorphisms in the DRD2, DRD3, and SLC6A3 gene in elderly patients with delirium. Am J Med Genet B Neuropsychiatr Genet in press.
71. Vandenbergh D.J., Persico A.M., Hawkins A.L., Griffin C.A., Li X., Jabs E.W., et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14 (1992) 1104-1106
72. Vaquero Lorenzo C., Baca-Garcia E., Hernandez M.D., Martin C.B., Perez-Rodriguez M.M., Saiz-Gonzalez M.D., et al. No association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and schizophrenia in a Spanish sample. Am J Med Genet B Neuropsychiatr Genet 144 (2007) 344-346
73. Virgos C., Martorell L., Valero J., Figuera L., Civeira F., Joven J., et al. Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr Res 49 (2001) 65-71
74. Williams J., Spurlock G., Holmans P., Mant R., Murphy K., Jones L., et al. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Mol Psychiatry 3 (1998) 141-149
75. Yang L., Li T., Wiese C., Lannfelt L., Sokoloff P., Xu C.T., et al. No association between schizophrenia and homozygosity at the D3 dopamine receptor gene. Am J Med Genet 48 (1993) 83-86
76. Zakzanis K.K., and Hansen K.T. Dopamine D2 densities and the schizophrenic brain. Schizophr Res 32 (1998) 201-206